Search Results 151-160 of 2909 for ⚙구글백링크프로그램 ※프로그램:GTTVTT 구글유흥광고 구글웹툰광고 구글스포츠중계광고⚙

  1. A Study of the ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids - Mayo Clinic

    ExAblate delivers a pulse of focused ultrasound energy, or sonication, to the targeted tissue. In this particular study, the targeted tissue is uterine fibroids ...

  2. Primary Myelofibrosis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate safety and tolerability of multi-kinase inhibitor LNK01002 in patients with primary myelofibrosis (MF), or MF due to ...

  3. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

    About this study. This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with ...

  4. Admissions - Center for Clinical and Translational Science

    D. Program. This program is officially known as the Medical Scientist Training Program and is jointly offered by Mayo Medical School and Mayo Graduate School.

  5. Biospecimens Resource for Glomerular and Tubulo-interstitial Diseases - Mayo Clinic

    This study is being done to create a "resource" of samples that can be used to improve our ability to diagnose and treat MN, IgAN, MPGN, FSGS/MCD, Lupus ...

  6. Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE) - Mayo Clinic

    About this study. The purpose of this study is to evaluate comparisons between a hybrid program of center-based CR which incorporates mHealth remote case ...

  7. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

  8. Zenith® p-Branch® OTS Multicenter Study - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

  10. Training Opportunities - Human Immunodeficiency Virus Lab: Andrew D. Badley - Mayo Clinic Research

    Training Opportunities. Mayo Clinic offers several education programs for aspiring researchers. M.D.-Ph.D. Program · Ph.D. Program: Virology and Gene ...